Modulation of P-glycoprotein expression by honokiol, magnololand 4-O-methylhonokiol, the bioactive components of Magnolia officinalis

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4445-4452

  Han, Hyo Kyung ^a   Van Anh, Luu Thi ^a  

^a Dongguk University   (South Korea)

Author keywords

4 O methylhonokiol; Gene expression; Honokiol; Magnolol; NCI ADR RES cells; P glycoprotein

Indexed keywords

4 O METHYLHONOKIOL; ANTINEOPLASTIC AGENT; DAUNORUBICIN; HONOKIOL; MAGNOLOL; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; DAUNORUBICIN; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LIGNANS; MAGNOLIA; P-GLYCOPROTEIN; PLANT EXTRACTS;

EID: 84867783256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Thun MJ, DeLancey JO, Center MM, Jemal A and Ward EM: The global burden of cancer: priorities for prevention. Carcinogenesis 31: 100-110, 2010.
3. Persidis A: Cancer multidrug resistance. Nat Biotechnol 17: 94-95, 1999.
4. Schinkel AH and Jonker JW: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55: 3-29, 2003. (Pubitemid 36078452)
5. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219-234, 2006. (Pubitemid 43336035)
6. Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP and Hsu HY: Two antiplatelet agents from Magnolia officinalis. Thromb Res 50: 757-765, 1988.
7. Shen JL, Man KM, Huang PH, Chen WC, Chen DC, Cheng YW, Liu PL, Chou MC and Chen YH: Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 15: 6452-6465, 2010.
8. Maruyama Y, Kuribara H, Morita M, Yuzurihara M and Weintraub ST: Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. J Nat Prod 61: 135-138, 1998. (Pubitemid 28086994)
9. Kim BH and Cho JY: Anti-inflammatory effect of honokiol is mediated by PI3K/AKT pathway suppression. Acta Pharmacol Sin 29: 113-122, 2008.
10. Ho KY, Tsai CC, Chen CP, Huang JS and Lin CC: Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis . Phytother Res 15: 139-141, 2001.
11. Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K and Eucker J: Antitumor effect of honokiol alone and in combination with other anticancer agents in breast cancer. Eur J Pharmacol 591: 43-51, 2008.
12. Xu D, Lu Q and Hu X: Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280, 2006. (Pubitemid 44485849)
13. Zeng B, Wu A, Chen J and Lai X: Study on transport characteristics of honokiol in Caco-2 cell model by HPLC. Zhongguo Zhong Yao Za Zhi 36: 1286-1290, 2011.
14. Zhang S, Yang X and Morris ME: Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65: 1208-1216, 2004. (Pubitemid 38543491)
15. Qiang F, Lee BJ, Ha I, Kang KW, Woo ER and Han HK: Effect of maceligan on the systemic exposure of paclitaxel: In vitro and in vivo evaluation. Eur J Pharm Sci 41: 226-231, 2010.
16. Callaghan R, Crowley E, Potter S and Kerr ID: P-Glycoprotein: So many ways to turn it on. J Clin Pharmacol 48: 365-378, 2008.
17. Liou KT, Shen YC, Chen CF, Tsao CM and Tsai SK: The anti-inflammatory effect of honokiol on neutrophils: Mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27, 2003.
18. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY and Liu SH: Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44: 2043-2050, 2008.
19. Dikalov S, Losik T and Arbiser JL: Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76: 589-596, 2008.
20. Heim KE, Tagliaferro AR and Bobilya DJ: Flavonoid antioxidants: chemistry, metabolism and structure activity relationships. J Nutr Biochem 13: 572-584, 2002. (Pubitemid 35246546)
21. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G and Arbiser JL: Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 35501-35507, 2003. (Pubitemid 37102321)
22. Battle TE, Arbiser J and Frank DA: The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697, 2005. (Pubitemid 40981267)